European high-end project investment has "capital guide" in Guangzhou. Yesterday morning, the Huangpu District Government, Guangzhou Development Zone Management Committee, Guangzhou Shixing Investment Co., Ltd. and Yinshan Capital Co., Ltd. signed the "China-Europe Belt and Road Industrial Fund" (hereinafter referred to as "China-Europe Fund"). The total fund size is expected. Over 10 billion yuan, with the first period of 2 billion yuan.

This is the first overseas investment fund established by the district since the issuance of the "10 Venture Capital Regulations" (the policy of "Guangzhou Huangpu District and Guangzhou Development Zone Promote Venture Capital Development Zone"), which will promote the "introduction of high-quality projects in Europe" and Excellent enterprises in Guangzhou "go global" to achieve two-way flow.

On the morning of the same day, Zhou Yawei, member of the Standing Committee of the Guangzhou Municipal Party Committee, Secretary of the Huangpu District Party Committee, Secretary of the Guangzhou Development Zone Party Working Committee and Director of the Management Committee, participated in the negotiation and signing of the China-Europe Fund.

Text/Guangzhou Daily All-Media Reporter He Ruiqi Correspondents Guo Zhehan and Li Zhougeng

"10 Venture Capital Investors" Give Up Overseas Investment

Guangzhou is making every effort to build the "China's venture capital capital". Huangpu District and Guangzhou Development Zone issued the "10 Venture Capital Investors" that lead the country's similar policies and represent Guangzhou's competitiveness last month. The annual budget special funding investment exceeds 300 million yuan, and A venture capital building was built in Science City and China News Service Guangzhou Knowledge City to "build a nest to attract phoenixes", which has attracted a large number of venture capital institutions to join the district to develop.

It is reported that China-Europe Fund is the first overseas investment fund to settle in the China Venture Capital Science City Building after the issuance of the "10 Venture Capital Investors" in the region.

The total scale of China-Europe Fund is expected to exceed 10 billion yuan, with the first period of 2 billion yuan, with RMB funds and US dollar funds. Among the first period of 2 billion yuan, RMB funds and US dollar funds each account for about half. RMB funds will be raised first, and US dollar funds will be established and raised within one and a half years after the RMB funds are raised.

China-Europe Fund's US dollar fund will invest in European companies with high-speed growth potential. As hidden champions in these fields, a "capital guide" for high-tech and high-end service companies to invest in Guangzhou, they will guide them to settle in the Guangzhou Development Zone first.

Vice versa, the RMB fund invests in outstanding enterprises in Guangzhou Development Zone, Guangzhou City and China in Huangpu District, and guides them to go global and expand their commercial market space in Europe.

The first batch of more than ten high-tech projects were introduced

The reporter learned from the signing ceremony that the projects that China-Europe Fund is recently introducing include setting up an international hospital in Huangpu District and Guangzhou Development Zone, and introducing more than a dozen domestic and foreign high-tech projects. In addition, in terms of education and training, the fund will introduce the "Education Training Science and Technology Incubation" project of internationally renowned universities.

According to the co-founder and chairman of Yinshan Capital Co., Ltd. (Molinze), the fund favors medical and health, education and training, cultural creativity, biomedicine and other fields. "Our investment cycle generally reaches 7 years, and the invested companies have basically reached a certain scale and have a profit rate."

According to reports, Yinshan Capital Co., Ltd. is an investment company established in Hong Kong in 2013. The total investment in funds and projects under management has exceeded 10 billion yuan. It has rich international and domestic high-tech, financial industry, medical, education and culture industries, etc., including international and domestic high-tech, financial industry, medical, education and culture industries, etc. contact channel network.

China and Europe move towards "two-way exchange"

In November 2013, the China National Development and Reform Commission and the European Commission's Regional Policy Department jointly listed Guangzhou Development Zone as the first pilot area for China-Europe regional policy cooperation. Over the past three years, the region's China-Europe cooperation work has made good progress. 30 China-Europe cooperation science and industry demonstration projects have been launched, with a total investment of 1.248 billion yuan. Among them, Guangzhou Hoshenyuan Company and French Merrier Group jointly built a R&D center in the region. ;Guangzhou Ruisong Intelligent Technology Company and Germany's IBG Industrial Group plan to establish a joint venture to carry out intelligent equipment and robotics technology research and development.

Another news that has attracted much attention from parents is that in the Changlingju section of the district, the Guangzhou Huangpu Xiushi Beili Experimental School, founded by Darwin's alma mater in the UK, will be built, and a private complete positioning of international education and school management will be built. High school, it is expected to be enrolled in fall 2019.

"China-Europe cooperation is changing from one-way investment promotion to two-way investment and cooperation in the past. Huangpu District will seize the opportunity of the Belt and Road Initiative to help more companies actively 'go global' to invest in the EU and form a mutually beneficial and win-win cooperation situation." Guangzhou A relevant person in charge of the Development Zone Development and Reform Bureau said.

At present, 15 companies in the region have invested in the EU, with a total investment of US$150 million. Among them, Xiangxue Pharmaceutical Company cooperated with the British Vannova Pharmaceutical Company to develop Chinese medicine preparations for isatis root. Guangzhou Wanfu Biotechnology has invested in Atlas Genetics Company in the UK for 125 million yuan.